These current affairs are written in a easy to remember format and are useful for competitive exams like - UPSC Civil Services, UPPSC, BPSC, MPPPSC, State PSCs and other competitive examinations.
EU COVID Digital Green Pass
The EU COVID Digital Green Pass is the popular form of the EU Digital COVID Certificate or EUDCC which is a digital (or paper) certificate that will enable a person to travel within and to the EU region covering 27 member-states.
The certificate will act as proof of the fact that the person concerned has been vaccinated or has recovered from COVID-19 or has a negative certificate on a COVID-19 test done 24 hours prior to travelling.
In principle, unvaccinated travellers can reach EU using the "negative certificate on a COVID-19 test done 24 hours prior to travelling" option in the green pass.
Unified District Information on School Education (UDISE) report
According to the UDISE+ report, the overall dropout rate of girls is 2% less than that of the boys.
The Unified District Information on School Education (UDISE), initiated in 2012-13 by the Ministry of Education by integrating the DISE for elementary education and the SEMIS for secondary education.
It is one of the largest management information systems on school education, covering more than 15 lakh schools, 85 lakh teachers and 25 crore children.
The UDISE+ is an updated and improved version of the UDISE.
Black Carbon has adverse effect on human health
A team of researchers found that Black Carbon has a significant adverse effect on human health and can lead to a premature death.
The Indo-Gangetic plain is exposed to Black Carbon (BC) with serious implications on regional climate and human health.
Read More: Black Carbon
Why is "ZyCov-D" vaccine different ?
If approved by the regulator, ZyCov-D will be the world's first DNA vaccine against infection with SARS-CoV-2.
ZyCov-D is a plasmid DNA vaccine ? or a vaccine that uses a genetically engineered, non-replicating version of a type of DNA molecule known as a plasmid.
ZyCov-D by contrast, will be given in three doses, with an interval of 28 days between the first and second and second and third shots.
No needle is used - instead, a spring-powered device delivers the shot as a narrow, precise stream of fluid that penetrates the skin.
ZyCov-D has been developed with the support of Department of Biotechnology and the Indian Council of Medical Research (ICMR).
Science & Tech